Article
Intrapartum exposure to nevirapine and subsequent maternal responses to nevirapine-based antiretroviral therapy.
The New England journal of medicine - 15 Jul 2004
Jourdain Gonzague, Ngo-Giang-Huong Nicole, Le Coeur Sophie, Bowonwatanuwong Chureeratana, Kantipong Pacharee, Leechanachai Pranee, Ariyadej Surabhon, Leenasirimakul Prattana, Hammer Scott, Lallemant Marc
Abstract excerpt
BACKGROUND: A single intrapartum dose of nevirapine for the prevention of mother-to-child transmission of human immunodeficiency virus (HIV) leads to the selection of resistance mutations. Whether there are clinically significant consequences in mothers who are subsequently treated with a nevirapine-containing regimen is unknown. METHODS: We randomly assigned 1844 women in Thailand who received zidovudine during...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
